GPAT2, also known as “cancer-testicular antigen”, is highly expressed in several cancer types (such as lung, melanoma, breast, and prostate cancer) and cancer-derived human cell lines, in which GPAT2 expression is associated with histological grading of the tumor. This evidence concerns the gene GPAT2 and neoplasm.